We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+19.78%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$45.9B
AUM Growth
+$5.92B
(+15%)
Cap. Flow
-$190M
Cap. Flow
% of AUM
-0.41%
Top 10 Holdings %
Top 10 Hldgs %
24.37%
Holding
916
New
168
Increased
229
Reduced
363
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$338M |
| 2 |
ExxonMobil
XOM
|
+$291M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$271M |
| 4 |
GE Aerospace
GE
|
+$205M |
| 5 |
Emerson Electric
EMR
|
+$157M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$310M |
| 2 |
Sensata Technologies
ST
|
+$251M |
| 3 |
Fortive
FTV
|
+$226M |
| 4 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$117M |
| 5 |
Honeywell
HON
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.79% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 12.96% |
| 4 | Financials | 12.38% |
| 5 | Communication Services | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JAMF
701
DELISTED
Jamf
JAMF
| $4.49M | 0.01% |
150,000
+25,000
| +20% | +$824K |
|
702
Oshkosh
OSK
$9.47B
| $4.36M | 0.01% |
50,674
+10,000
| +25% | +$796K |
|
703
Acadia Pharmaceuticals
ACAD
$4.9B
| $4.28M | 0.01% |
+80,000
| New | +$3.97M |
|
704
Alpha Metallurgical Resources
AMR
$1.93B
| $4.09M | 0.01% |
360,000
-187,928
| -34% | -$1.69M |
|
705
HF Sinclair
DINO
$14.7B
| $4.07M | 0.01% |
157,300
-6,500
| -4% | -$147K |
|
|
FARM
706
DELISTED
Farmer Brothers
FARM
| $4.06M | 0.01% |
869,699
| – | – |
|
|
ERF
707
DELISTED
Enerplus Corporation
ERF
| $3.91M | 0.01% |
1,250,000
+1,000,000
| +400% | +$2.43M |
|
708
Unity
U
$17.8B
| $3.84M | 0.01% |
25,000
-25,000
| -50% | -$3.04M |
|
709
First Horizon
FHN
$12.1B
| $3.83M | 0.01% |
300,117
-2,439,410
| -89% | -$28.6M |
|
710
RingCentral
RNG
$5.18B
| $3.79M | 0.01% |
10,000
-10,000
| -50% | -$3.11M |
|
711
Myriad Genetics
MYGN
$304M
| $3.78M | 0.01% |
+191,310
| New | +$3.09M |
|
712
W.R. Berkley
WRB
$26.8B
| $3.76M | 0.01% |
+127,350
| New | +$3.67M |
|
|
FCACU
713
DELISTED
Falcon Capital Acquisition Corp. Unit
FCACU
| $3.74M | 0.01% |
+350,000
| New | +$3.63M |
|
714
Gilead Sciences
GILD
$162B
| $3.73M | 0.01% |
63,977
-231,000
| -78% | -$13.9M |
|
715
Stoke Therapeutics
STOK
$2.06B
| $3.72M | 0.01% |
60,000
-75,050
| -56% | -$3.44M |
|
|
APSG.WS
716
DELISTED
Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer
APSG.WS
| $3.67M | 0.01% |
+1,951,866
| New | +$3.07M |
|
|
GNMK
717
DELISTED
GenMark Diagnostics, Inc
GNMK
| $3.65M | 0.01% |
+250,000
| New | +$3.31M |
|
718
Twilio
TWLO
$29.3B
| $3.38M | 0.01% |
+10,000
| New | +$3.12M |
|
719
Snap-on
SNA
$21.5B
| $3.36M | 0.01% |
+19,633
| New | +$3.28M |
|
720
Evercore
EVR
$12B
| $3.33M | 0.01% |
+30,402
| New | +$2.71M |
|
|
JG
721
Aurora Mobile
JG
$28.5M
| $3.32M | 0.01% |
+46,667
| New | +$2.37M |
|
|
CFRX
722
DELISTED
ContraFect Corporation
CFRX
| $3.28M | 0.01% |
8,125
| – | – |
|
|
BTRS
723
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $3.23M | 0.01% |
+200,000
| New | +$2.55M |
|
|
EXTN
724
DELISTED
Exterran Corporation
EXTN
| $3.09M | 0.01% |
700,000
+250,000
| +56% | +$1.07M |
|
725
Delcath Systems
DCTH
$534M
| $3.03M | 0.01% |
+168,963
| New | +$2.32M |
|
Similar funds
Adage Capital Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Adage Capital Partners held 916 positions worth $45.9B, up 15% from $39.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Adage Capital Partners's Q4 2020 filing shows 168 new, 229 increased, 363 reduced and 115 closed positions. Its largest new stake was Tesla: 1,978,500 shares worth $465M. The largest sale was Royalty Pharma, an estimated $310M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Adage Capital Partners's largest Q4 2020 buy was Tesla: 1,978,500 shares worth $465M.
- Adage Capital Partners added most to ExxonMobil in Q4 2020, an estimated $291M increase.
- Adage Capital Partners's biggest Q4 2020 reduction was Royalty Pharma, cutting an estimated $310M.
- Adage Capital Partners fully exited Sensata Technologies in Q4 2020, selling an estimated $251M.
- Adage Capital Partners's ten largest holdings make up 24% of its $45.9B portfolio in Q4 2020.
- Adage Capital Partners opened 168 new positions and closed 115 in Q4 2020.
- Adage Capital Partners's portfolio value rose 15% quarter-over-quarter to $45.9B.
Based on Adage Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.